IQVIA Pharma Deals Review of 2018

White Paper

March 26, 2019
IQVIA Pharma Deals  Review of 2018

The IQVIA Pharma Deals Review of 2018 provides an insightful overview of deal activity in 2018, as well as the outlook for deals in 2019. Key information provided includes the following:

  • Top M&A and partnership deals in 2018
  • Deal activity rankings of the top pharmaceutical companies
  • Deal activity by therapeutic area and development phase
  • Deal value analysis of M&A, licensing and R&D deals

Key highlights:

Deal activity in the life sciences sector slowed in 2018 as political uncertainty, leadership changes and changing regulatory and pricing landscapes took a toll. As was the case in 2017, small companies had various financing options available to them resulting in inflated company valuations which thereby discouraged pharmaceutical companies from certain types of dealmaking.

Get more details about IQVIA Pharma Deals today.